Your browser doesn't support javascript.
loading
Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants.
Leppälä, J M; Virtamo, J; Fogelholm, R; Albanes, D; Heinonen, O P.
Affiliation
  • Leppälä JM; Department of Public Health, University of Helsinki, Finland. jaana.leppala@helsinki.fi
Stroke ; 30(12): 2535-40, 1999 Dec.
Article in En | MEDLINE | ID: mdl-10582974
ABSTRACT
BACKGROUND AND

PURPOSE:

Blood pressure is an important risk factor for stroke, but the roles of serum total and HDL cholesterol, alpha-tocopherol, and beta-carotene are poorly established. We studied these factors in relation to stroke subtypes.

METHODS:

Male smokers (n=28 519) aged 50 to 69 years without a history of stroke participated in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study, a controlled trial to test the effect of alpha-tocopherol and beta-carotene supplementation on cancer. From 1985 to 1993, a total of 1057 men suffered from primary stroke 85 had subarachnoid hemorrhage; 112, intracerebral hemorrhage; 807, cerebral infarction; and 53, unspecified stroke.

RESULTS:

Systolic blood pressure > or = 160 mm Hg increased the risk of all stroke subtypes 2.5 to 4-fold. Serum total cholesterol was inversely associated with the risk of intracerebral hemorrhage, whereas the risk of cerebral infarction was raised at concentrations > or = 7.0 mmol/L. The risks of subarachnoid hemorrhage and cerebral infarction were lowered with serum HDL cholesterol levels > or = 0.85 mmol/L. Pretrial high serum alpha-tocopherol decreased the risk of intracerebral hemorrhage by half and cerebral infarction by one third, whereas high serum beta-carotene doubled the risk of subarachnoid hemorrhage and decreased that of cerebral infarction by one fifth.

CONCLUSIONS:

The risk factor profiles of stroke subtypes differ, reflecting different etiopathology. Because reducing atherosclerotic diseases, including ischemic stroke, by lowering high serum cholesterol is one of the main targets in public health care, further studies are needed to distinguish subjects with risk of hemorrhagic stroke. The performance of antioxidants needs confirmation from clinical trials.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Stroke Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Stroke Year: 1999 Document type: Article Affiliation country: Finland
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Stroke Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Stroke Year: 1999 Document type: Article Affiliation country: Finland